Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis

Continuous Versus Interrupted Use.of Vaginal Probiotic Plus Vaginal Clindamycin Cream for Bacterial Vaginosis a Randomized Controlled Study

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03234517

Enrollment

200

Registered

2017-07-31

Start date

2016-08-01

Completion date

2018-08-31

Last updated

2018-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Vaginosis Treatment

Brief summary

Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis

Detailed description

Vaginal Clindamycin Cream was used initially for treatment of Bacterial Vaginosis followed by Vaginal probiotic either in cnotinous or interrupted manner, then assessment of the results of treatment at different time intervals was done.

Interventions

DRUGVaginal Clindamycin Cream

Vaginal Clindamycin Cream

DRUGVaginal Probiotic

Vaginal Probiotic

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* more than 18 years * has recurrent Bacterial Vaginosis

Exclusion criteria

* pregnancy * use of other antmicrobial * not provide informed consent

Design outcomes

Primary

Measure	Time frame	Description
initial cure rate	2 months	number of women completely cured

Secondary

Measure	Time frame	Description
recurrence rate	4,6,8and12 months	number of women had recurrence

Countries

Egypt

Contacts

Primary ContactIbrahim A EL sharkwy

ibrahimsharkwy@yahoo.com00966554818576

Backup ContactMohamed L Elsayed

drmohamedlotfy@yahoo.com00201222442467

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026